James Hassard serves as our Executive Vice President, Chief Commercial Officer. Prior to joining Aligos, Jim was Chief Commercial Officer at Crinetics Pharmaceuticals and Arrowhead Pharmaceuticals where he built the commercial capabilities and launch strategies for more than four rare disease programs. Earlier in his career, Mr. Hassard held positions of increasing responsibility at Coherus Oncology, Amgen, and Merck, launching multiple pharmaceutical products in therapeutic areas including hepatitis, oncology, and nephrology. He has global experience in the United States, Canada and Europe, including as general manager of Amgen Portugal. Mr. Hassard earned a Bachelor of Science in Pharmacology from the University of Toronto, followed by a Master’s in Business Administration from Nova Southeastern University.